[Clinical-pharmacological study on the effectiveness of acetic acid-(4-(2-dimethylamino-ethoxy)-5-isopropyl-2-methyl-phenyl)ester-HCl (moxisylyt)].
D000085:Acetates / Q000008:administration & dosage / Q000494:pharmacology; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001808:Blood Vessels / Q000187:drug effects; D004106:Dilatation; D004952:Esters / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D008744:Methylamines / Q000494:pharmacology; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage; D010919:Placebos; D010992:Plethysmography, Impedance; D012039:Regional Blood Flow / Q000187:drug effects*; D013729:Terpenes / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
D000085:Acetates; D004952:Esters; D008744:Methylamines; D010636:Phenols; D010919:Placebos; D013729:Terpenes; D014665:Vasodilator Agents
Klinisch-pharmakologischer Nachweis der Wirkung von Essigsäure-(4-(2-dimethylamino-aethoxy)-5-isopropyl-2-methyl-phenyl)-ester-HCl (Moxisylyt.